OCUMETICS TECHNOLOGY CORP (OTC.CA) Stock Price & Overview

TSX-V:OTCCA67577H1047

Current stock price

0.49 CAD
+0.04 (+10.11%)
Last:

The current stock price of OTC.CA is 0.49 CAD. Today OTC.CA is up by 10.11%. In the past month the price increased by 13.95%. In the past year, price increased by 88.46%.

OTC.CA Key Statistics

52-Week Range0.26 - 1.99
Current OTC.CA stock price positioned within its 52-week range.
1-Month Range0.35 - 0.5
Current OTC.CA stock price positioned within its 1-month range.
Market Cap
63.524M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.04
Dividend Yield
N/A

OTC.CA Stock Performance

Today
+10.11%
1 Week
+11.36%
1 Month
+13.95%
3 Months
-12.50%
Longer-term
6 Months -53.77%
1 Year +88.46%
2 Years +55.56%
3 Years +44.12%
5 Years N/A
10 Years N/A

OTC.CA Stock Chart

OCUMETICS TECHNOLOGY CORP / OTC Daily stock chart

OTC.CA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to OTC.CA. When comparing the yearly performance of all stocks, OTC.CA is one of the better performing stocks in the market, outperforming 77.04% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OTC.CA Earnings

Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ3 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

OTC.CA Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

OTC.CA Groups

Sector & Classification

Index Membership

OTC.CA Financial Highlights

Over the last trailing twelve months OTC.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS decreased by -45.45% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-4.24M
Industry RankSector Rank
PM (TTM) N/A
ROA -259.88%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-65.62%
Sales Q2Q%N/A
EPS 1Y (TTM)-45.45%
Revenue 1Y (TTM)N/A

OTC.CA Ownership

Ownership
Inst OwnersN/A
Shares129.64M
Float77.72M
Ins Owners40.05%
Short Float %N/A
Short RatioN/A

About OTC.CA

Company Profile

OTC logo image Ocumetics Technology Corp. engages in the development of bio lenses to completely eliminate the need for corrective lenses, especially for people over 45 years of age. The company is headquartered in Calgary, Alberta. The company went IPO on 2018-08-29. The firm specializes in adaptive lens designs. The firm is focused on developing an accommodating intraocular lens. The Ocumetics lens is an expandable intraocular lens that fits within the natural lens compartment of the eye with the objective of eliminating the need for corrective lenses. The company is designed to allow the eye’s natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses. The Lens consists of self-adapting suspension systems that modulate curvature change. The Lens’s suspension systems are comprised of cushions that are designed to conform to unique parameters of each recipient’s eye. When ciliary muscles relax, during sleep or when the eye focuses upon distant objects, the optical interface is compressed into its high energy state by expansion of the suspension system.

Company Info

IPO: 2018-08-29

OCUMETICS TECHNOLOGY CORP

1250, 639 - 5th Avenue S.W.

Calgary ALBERTA CA

Employees: 0

OTC Company Website

OTC Investor Relations

Phone: 14036507718

OCUMETICS TECHNOLOGY CORP / OTC.CA FAQ

What does OCUMETICS TECHNOLOGY CORP do?

Ocumetics Technology Corp. engages in the development of bio lenses to completely eliminate the need for corrective lenses, especially for people over 45 years of age. The company is headquartered in Calgary, Alberta. The company went IPO on 2018-08-29. The firm specializes in adaptive lens designs. The firm is focused on developing an accommodating intraocular lens. The Ocumetics lens is an expandable intraocular lens that fits within the natural lens compartment of the eye with the objective of eliminating the need for corrective lenses. The company is designed to allow the eye’s natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses. The Lens consists of self-adapting suspension systems that modulate curvature change. The Lens’s suspension systems are comprised of cushions that are designed to conform to unique parameters of each recipient’s eye. When ciliary muscles relax, during sleep or when the eye focuses upon distant objects, the optical interface is compressed into its high energy state by expansion of the suspension system.


Can you provide the latest stock price for OCUMETICS TECHNOLOGY CORP?

The current stock price of OTC.CA is 0.49 CAD. The price increased by 10.11% in the last trading session.


Does OCUMETICS TECHNOLOGY CORP pay dividends?

OTC.CA does not pay a dividend.


How is the ChartMill rating for OCUMETICS TECHNOLOGY CORP?

OTC.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.